e-Therapeutics Expects to Receive Payments From Galapagos
By Adria Calatayud
e-Therapeutics PLC said Friday that it expects to receive
payments from Galapagos NV after meeting two milestones under a
collaboration agreement between the two companies.
U.K.-based e-Therapeutics, a provider of technology services for
drug discovery, said the collaboration--which seeks to identify new
therapeutic approaches for the treatment of idiopathic pulmonary
fibrosis and other fibrotic conditions--has remained on schedule
despite the coronavirus pandemic.
Under the terms of its agreement with Galapagos, e-therapeutics
is eligible to receive additional milestone payments, it said.
Write to Adria Calatayud at email@example.com
(END) Dow Jones Newswires
April 23, 2021 03:08 ET (07:08 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.